Novartis (NYSE: NVS) reported Q1 EPS of $1.13, $0.01 better than the analyst estimate of $1.12. Revenue for the quarter came in at $11.5 billion versus the consensus estimate of $11.65 billion.

Novartis confirmed FY17 outlook.

For earnings history and earnings-related data on Novartis (NVS) click here.